298 related articles for article (PubMed ID: 25012064)
1. Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers.
Loyer P; Cammas-Marion S
J Drug Target; 2014 Aug; 22(7):556-75. PubMed ID: 25012064
[TBL] [Abstract][Full Text] [Related]
2. Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices.
Cammas S; Béar MM; Moine L; Escalup R; Ponchel G; Kataoka K; Guérin P
Int J Biol Macromol; 1999; 25(1-3):273-82. PubMed ID: 10416675
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
4. New functional degradable and bio-compatible nanoparticles based on poly(malic acid) derivatives for site-specific anti-cancer drug delivery.
Huang ZW; Laurent V; Chetouani G; Ljubimova JY; Holler E; Benvegnu T; Loyer P; Cammas-Marion S
Int J Pharm; 2012 Feb; 423(1):84-92. PubMed ID: 21550387
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
Arif M; Raja MA; Zeenat S; Chi Z; Liu C
J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
[TBL] [Abstract][Full Text] [Related]
6. Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
Fujita M; Lee BS; Khazenzon NM; Penichet ML; Wawrowsky KA; Patil R; Ding H; Holler E; Black KL; Ljubimova JY
J Control Release; 2007 Oct; 122(3):356-63. PubMed ID: 17630012
[TBL] [Abstract][Full Text] [Related]
7. Poly(malic acid) bearing Doxorubicin and N-Acetyl Galactosamine as a site-specific prodrug for targeting hepatocellular carcinoma.
Venkatraj N; Nanjan MJ; Loyer P; Chandrasekar MJN; Cammas Marion S
J Biomater Sci Polym Ed; 2017; 28(10-12):1140-1157. PubMed ID: 28357894
[TBL] [Abstract][Full Text] [Related]
8. Improved synthesis with high yield and increased molecular weight of poly(alpha,beta-malic acid) by direct polycondensation.
Kajiyama T; Kobayashi H; Taguchi T; Kataoka K; Tanaka J
Biomacromolecules; 2004; 5(1):169-74. PubMed ID: 14715023
[TBL] [Abstract][Full Text] [Related]
9. Opsonisation of nanoparticles prepared from poly(β-hydroxybutyrate) and poly(trimethylene carbonate)-b-poly(malic acid) amphiphilic diblock copolymers: Impact on the in vitro cell uptake by primary human macrophages and HepaRG hepatoma cells.
Vene E; Barouti G; Jarnouen K; Gicquel T; Rauch C; Ribault C; Guillaume SM; Cammas-Marion S; Loyer P
Int J Pharm; 2016 Nov; 513(1-2):438-452. PubMed ID: 27640247
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
11. Polycefin, a new prototype of a multifunctional nanoconjugate based on poly(beta-L-malic acid) for drug delivery.
Lee BS; Fujita M; Khazenzon NM; Wawrowsky KA; Wachsmann-Hogiu S; Farkas DL; Black KL; Ljubimova JY; Holler E
Bioconjug Chem; 2006; 17(2):317-26. PubMed ID: 16536461
[TBL] [Abstract][Full Text] [Related]
12. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
Nicolas J; Mura S; Brambilla D; Mackiewicz N; Couvreur P
Chem Soc Rev; 2013 Feb; 42(3):1147-235. PubMed ID: 23238558
[TBL] [Abstract][Full Text] [Related]
13. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
14. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
Elzoghby AO
J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
[TBL] [Abstract][Full Text] [Related]
15. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
Ljubimova JY; Portilla-Arias J; Patil R; Ding H; Inoue S; Markman JL; Rekechenetskiy A; Konda B; Gangalum PR; Chesnokova A; Ljubimov AV; Black KL; Holler E
J Drug Target; 2013 Dec; 21(10):956-967. PubMed ID: 24032759
[TBL] [Abstract][Full Text] [Related]
17. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Lakkakula JR; Maçedo Krause RW
Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
[TBL] [Abstract][Full Text] [Related]
18. Polymer-drug conjugates: present state of play and future perspectives.
Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX
Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841
[TBL] [Abstract][Full Text] [Related]
19. Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer Activity.
Zhou Q; Hou Y; Zhang L; Wang J; Qiao Y; Guo S; Fan L; Yang T; Zhu L; Wu H
Theranostics; 2017; 7(7):1806-1819. PubMed ID: 28638469
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable nanoparticles of partially methylated fungal poly(beta-L-malic acid) as a novel protein delivery carrier.
Portilla-Arias JA; García-Alvarez M; Galbis JA; Muñoz-Guerra S
Macromol Biosci; 2008 Jun; 8(6):551-9. PubMed ID: 18350538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
